Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colorectal Neoplasms, Hereditary Nonpolyposis | 75 | 2025 | 388 | 11.180 |
Why?
|
Genetic Testing | 47 | 2025 | 3594 | 3.930 |
Why?
|
Germ-Line Mutation | 45 | 2024 | 1885 | 3.460 |
Why?
|
Colorectal Neoplasms | 67 | 2024 | 6961 | 3.160 |
Why?
|
DNA Mismatch Repair | 29 | 2023 | 432 | 3.080 |
Why?
|
Pancreatic Neoplasms | 35 | 2024 | 5454 | 2.630 |
Why?
|
Colonoscopy | 27 | 2024 | 1408 | 2.310 |
Why?
|
MutS Homolog 2 Protein | 24 | 2023 | 200 | 2.290 |
Why?
|
Neoplastic Syndromes, Hereditary | 12 | 2024 | 249 | 2.070 |
Why?
|
Genetic Predisposition to Disease | 58 | 2024 | 18076 | 2.050 |
Why?
|
Carcinoma, Pancreatic Ductal | 14 | 2024 | 1762 | 1.920 |
Why?
|
Adenomatous Polyposis Coli | 10 | 2020 | 219 | 1.780 |
Why?
|
Intestinal Polyposis | 7 | 2022 | 42 | 1.480 |
Why?
|
Colonic Polyps | 12 | 2024 | 557 | 1.390 |
Why?
|
Medical History Taking | 9 | 2021 | 779 | 1.350 |
Why?
|
Microsatellite Instability | 11 | 2023 | 726 | 1.300 |
Why?
|
Hamartoma Syndrome, Multiple | 6 | 2022 | 115 | 1.250 |
Why?
|
DNA Glycosylases | 8 | 2020 | 125 | 1.230 |
Why?
|
Peutz-Jeghers Syndrome | 6 | 2022 | 61 | 1.140 |
Why?
|
Genetic Counseling | 7 | 2024 | 634 | 1.130 |
Why?
|
Risk Assessment | 30 | 2025 | 24276 | 1.100 |
Why?
|
Early Detection of Cancer | 27 | 2024 | 3238 | 1.090 |
Why?
|
Carcinoma | 10 | 2020 | 2313 | 1.000 |
Why?
|
Adaptor Proteins, Signal Transducing | 21 | 2015 | 2898 | 0.910 |
Why?
|
Endometrial Neoplasms | 13 | 2021 | 1379 | 0.910 |
Why?
|
Adenoma | 11 | 2024 | 2155 | 0.880 |
Why?
|
Models, Genetic | 8 | 2021 | 3448 | 0.870 |
Why?
|
Gastrointestinal Hemorrhage | 10 | 2022 | 1127 | 0.860 |
Why?
|
Nuclear Proteins | 24 | 2017 | 5791 | 0.850 |
Why?
|
Pedigree | 23 | 2021 | 4535 | 0.790 |
Why?
|
Li-Fraumeni Syndrome | 4 | 2015 | 116 | 0.770 |
Why?
|
Mass Screening | 19 | 2021 | 5450 | 0.740 |
Why?
|
BRCA2 Protein | 5 | 2021 | 802 | 0.730 |
Why?
|
DNA-Binding Proteins | 18 | 2021 | 9601 | 0.680 |
Why?
|
Colonic Neoplasms | 11 | 2022 | 2532 | 0.680 |
Why?
|
Gastrointestinal Neoplasms | 3 | 2024 | 958 | 0.620 |
Why?
|
Adenomatous Polyposis Coli Protein | 3 | 2017 | 182 | 0.610 |
Why?
|
Telemedicine | 3 | 2024 | 3108 | 0.580 |
Why?
|
Mutation | 35 | 2022 | 30209 | 0.580 |
Why?
|
Genes, APC | 3 | 2020 | 144 | 0.560 |
Why?
|
Colectomy | 8 | 2020 | 697 | 0.550 |
Why?
|
Middle Aged | 108 | 2025 | 223083 | 0.530 |
Why?
|
BRCA1 Protein | 2 | 2021 | 1155 | 0.530 |
Why?
|
Humans | 207 | 2025 | 766117 | 0.530 |
Why?
|
Adenomatous Polyps | 6 | 2020 | 109 | 0.530 |
Why?
|
Gastroenterology | 4 | 2016 | 593 | 0.530 |
Why?
|
Heterozygote | 16 | 2022 | 2796 | 0.510 |
Why?
|
Telangiectasia, Hereditary Hemorrhagic | 3 | 2022 | 144 | 0.510 |
Why?
|
Hamartoma | 3 | 2022 | 235 | 0.500 |
Why?
|
Neoplasms | 15 | 2024 | 22344 | 0.500 |
Why?
|
Neoplasm Proteins | 14 | 2018 | 3594 | 0.490 |
Why?
|
Male | 116 | 2025 | 363935 | 0.450 |
Why?
|
Female | 123 | 2025 | 396233 | 0.440 |
Why?
|
Predictive Value of Tests | 19 | 2020 | 15403 | 0.430 |
Why?
|
Aged | 82 | 2025 | 171219 | 0.420 |
Why?
|
Adult | 88 | 2025 | 223139 | 0.420 |
Why?
|
DNA Mutational Analysis | 11 | 2017 | 4112 | 0.400 |
Why?
|
Watchful Waiting | 3 | 2021 | 492 | 0.390 |
Why?
|
Precancerous Conditions | 5 | 2024 | 975 | 0.390 |
Why?
|
DNA, Neoplasm | 6 | 2012 | 1739 | 0.390 |
Why?
|
Base Pair Mismatch | 3 | 2012 | 93 | 0.380 |
Why?
|
Genes, BRCA2 | 5 | 2019 | 591 | 0.370 |
Why?
|
Jews | 3 | 2020 | 359 | 0.360 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2017 | 2946 | 0.350 |
Why?
|
Feces | 3 | 2006 | 1503 | 0.340 |
Why?
|
Occult Blood | 4 | 2024 | 199 | 0.340 |
Why?
|
Intention | 2 | 2014 | 346 | 0.340 |
Why?
|
Gastrointestinal Tract | 1 | 2016 | 834 | 0.330 |
Why?
|
Risk Factors | 38 | 2024 | 74857 | 0.330 |
Why?
|
Medical Oncology | 3 | 2016 | 2339 | 0.320 |
Why?
|
Logistic Models | 11 | 2017 | 13273 | 0.310 |
Why?
|
Lower Gastrointestinal Tract | 2 | 2005 | 13 | 0.310 |
Why?
|
Standard of Care | 2 | 2012 | 568 | 0.300 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2013 | 698 | 0.300 |
Why?
|
Radiotherapy | 2 | 2020 | 1491 | 0.300 |
Why?
|
SEER Program | 4 | 2024 | 1443 | 0.300 |
Why?
|
Genes, BRCA1 | 3 | 2017 | 753 | 0.300 |
Why?
|
Anxiety | 2 | 2024 | 4672 | 0.290 |
Why?
|
Aged, 80 and over | 33 | 2024 | 59515 | 0.280 |
Why?
|
Family | 4 | 2024 | 3208 | 0.280 |
Why?
|
Endoscopy, Digestive System | 2 | 2014 | 358 | 0.280 |
Why?
|
Pancreatic Cyst | 4 | 2021 | 373 | 0.270 |
Why?
|
Proto-Oncogene Proteins | 7 | 2014 | 4521 | 0.270 |
Why?
|
Endosonography | 4 | 2021 | 626 | 0.270 |
Why?
|
Colonic Diseases | 1 | 2008 | 205 | 0.270 |
Why?
|
Immunohistochemistry | 6 | 2017 | 11035 | 0.260 |
Why?
|
Stomach Neoplasms | 2 | 2019 | 1471 | 0.260 |
Why?
|
Colorectal Surgery | 2 | 2020 | 125 | 0.260 |
Why?
|
Age Factors | 10 | 2021 | 18386 | 0.260 |
Why?
|
Microsatellite Repeats | 8 | 2012 | 784 | 0.260 |
Why?
|
Genes, Neoplasm | 2 | 2018 | 369 | 0.260 |
Why?
|
Carrier Proteins | 10 | 2014 | 4910 | 0.250 |
Why?
|
DNA Repair | 4 | 2018 | 2048 | 0.250 |
Why?
|
Germ Cells | 4 | 2021 | 646 | 0.250 |
Why?
|
Rectal Neoplasms | 2 | 2005 | 1183 | 0.250 |
Why?
|
Patient Compliance | 2 | 2013 | 2694 | 0.250 |
Why?
|
Pancreatic Juice | 3 | 2014 | 60 | 0.250 |
Why?
|
Neoplasms, Multiple Primary | 4 | 2016 | 590 | 0.240 |
Why?
|
Heredity | 5 | 2021 | 149 | 0.240 |
Why?
|
Radiotherapy, Adjuvant | 2 | 2016 | 1777 | 0.240 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2009 | 521 | 0.230 |
Why?
|
Cross-Sectional Studies | 14 | 2021 | 26290 | 0.230 |
Why?
|
Phenotype | 14 | 2021 | 16716 | 0.230 |
Why?
|
Genes, p53 | 2 | 2008 | 711 | 0.230 |
Why?
|
Prenatal Diagnosis | 2 | 2011 | 1271 | 0.220 |
Why?
|
Awareness | 1 | 2008 | 653 | 0.220 |
Why?
|
Aftercare | 2 | 2020 | 915 | 0.220 |
Why?
|
Minority Groups | 2 | 2008 | 1208 | 0.220 |
Why?
|
Cohort Studies | 20 | 2025 | 41684 | 0.220 |
Why?
|
Carcinoma, Papillary | 1 | 2009 | 786 | 0.220 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2019 | 3546 | 0.210 |
Why?
|
Founder Effect | 1 | 2004 | 185 | 0.210 |
Why?
|
Sequence Analysis, DNA | 5 | 2019 | 4780 | 0.210 |
Why?
|
Fibromatosis, Aggressive | 1 | 2004 | 125 | 0.210 |
Why?
|
Stomach Diseases | 2 | 2020 | 134 | 0.210 |
Why?
|
Stress, Psychological | 1 | 2018 | 4527 | 0.200 |
Why?
|
Molecular Diagnostic Techniques | 3 | 2016 | 614 | 0.200 |
Why?
|
Risk | 7 | 2018 | 9599 | 0.190 |
Why?
|
Disclosure | 1 | 2008 | 756 | 0.190 |
Why?
|
Family Health | 4 | 2011 | 1253 | 0.190 |
Why?
|
Young Adult | 17 | 2024 | 59868 | 0.190 |
Why?
|
Models, Statistical | 4 | 2022 | 5089 | 0.190 |
Why?
|
Tumor Suppressor Proteins | 4 | 2017 | 2795 | 0.190 |
Why?
|
Population Surveillance | 5 | 2019 | 2596 | 0.180 |
Why?
|
Blood Glucose Self-Monitoring | 1 | 2004 | 475 | 0.180 |
Why?
|
Poverty | 3 | 2014 | 2714 | 0.180 |
Why?
|
Eflornithine | 1 | 2020 | 31 | 0.180 |
Why?
|
Advisory Committees | 6 | 2020 | 796 | 0.180 |
Why?
|
Sulindac | 1 | 2020 | 29 | 0.180 |
Why?
|
DNA Repair Enzymes | 4 | 2016 | 342 | 0.180 |
Why?
|
Pancreas | 5 | 2022 | 1699 | 0.180 |
Why?
|
Community Health Centers | 1 | 2024 | 469 | 0.180 |
Why?
|
Bone Morphogenetic Protein Receptors, Type I | 1 | 2020 | 97 | 0.170 |
Why?
|
Intestinal Diseases | 1 | 2005 | 506 | 0.170 |
Why?
|
Social Class | 2 | 2009 | 2007 | 0.170 |
Why?
|
Penetrance | 3 | 2017 | 388 | 0.170 |
Why?
|
Practice Guidelines as Topic | 5 | 2020 | 7424 | 0.170 |
Why?
|
Sex Factors | 7 | 2021 | 10614 | 0.170 |
Why?
|
Polyps | 3 | 2012 | 200 | 0.170 |
Why?
|
Adenocarcinoma | 5 | 2019 | 6363 | 0.170 |
Why?
|
Breast Neoplasms | 8 | 2022 | 21074 | 0.170 |
Why?
|
Prenylation | 1 | 2019 | 36 | 0.160 |
Why?
|
Smad4 Protein | 1 | 2020 | 194 | 0.160 |
Why?
|
Insurance, Health | 2 | 2009 | 2520 | 0.160 |
Why?
|
Genes, p16 | 2 | 2017 | 157 | 0.160 |
Why?
|
Intestinal Neoplasms | 1 | 2021 | 314 | 0.160 |
Why?
|
Prevalence | 11 | 2024 | 15827 | 0.150 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 4 | 2019 | 1765 | 0.150 |
Why?
|
Carboxypeptidase B | 1 | 2018 | 6 | 0.150 |
Why?
|
Carboxypeptidases A | 1 | 2018 | 27 | 0.150 |
Why?
|
Gene Frequency | 4 | 2020 | 3623 | 0.150 |
Why?
|
United States | 24 | 2024 | 72920 | 0.150 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2018 | 8612 | 0.150 |
Why?
|
ROC Curve | 4 | 2017 | 3614 | 0.150 |
Why?
|
Patient Selection | 2 | 2009 | 4249 | 0.150 |
Why?
|
Neuroendocrine Tumors | 2 | 2021 | 657 | 0.150 |
Why?
|
Intestinal Polyps | 3 | 2022 | 105 | 0.150 |
Why?
|
rab GTP-Binding Proteins | 1 | 2019 | 247 | 0.140 |
Why?
|
Prognosis | 9 | 2022 | 29912 | 0.140 |
Why?
|
Cholelithiasis | 1 | 1999 | 408 | 0.140 |
Why?
|
Parents | 2 | 2011 | 3591 | 0.140 |
Why?
|
Antineoplastic Agents | 4 | 2020 | 13635 | 0.140 |
Why?
|
Multivariate Analysis | 7 | 2012 | 12061 | 0.140 |
Why?
|
Cell Adhesion Molecules | 3 | 2014 | 1610 | 0.130 |
Why?
|
Cholecystectomy | 1 | 1999 | 409 | 0.130 |
Why?
|
Proctocolectomy, Restorative | 1 | 1998 | 191 | 0.130 |
Why?
|
Sequence Deletion | 2 | 2011 | 1494 | 0.130 |
Why?
|
Adolescent | 13 | 2021 | 88819 | 0.130 |
Why?
|
Quality Indicators, Health Care | 3 | 2016 | 1804 | 0.130 |
Why?
|
Decision Support Techniques | 2 | 2004 | 2006 | 0.130 |
Why?
|
Private Practice | 1 | 2016 | 154 | 0.130 |
Why?
|
Adenosine Triphosphatases | 3 | 2015 | 839 | 0.130 |
Why?
|
Inheritance Patterns | 1 | 2018 | 345 | 0.130 |
Why?
|
Urologic Neoplasms | 1 | 2019 | 312 | 0.130 |
Why?
|
Health Knowledge, Attitudes, Practice | 4 | 2015 | 4054 | 0.120 |
Why?
|
Medical Records | 3 | 2007 | 1408 | 0.120 |
Why?
|
Genetic Markers | 2 | 2011 | 2603 | 0.120 |
Why?
|
Intestine, Small | 1 | 2021 | 1216 | 0.120 |
Why?
|
Risk Reduction Behavior | 1 | 2021 | 1121 | 0.120 |
Why?
|
Muir-Torre Syndrome | 1 | 2014 | 12 | 0.120 |
Why?
|
Antigens, Neoplasm | 3 | 2014 | 1996 | 0.120 |
Why?
|
Social Behavior | 1 | 2021 | 1143 | 0.120 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2015 | 702 | 0.120 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2016 | 305 | 0.120 |
Why?
|
Consensus | 6 | 2020 | 3202 | 0.120 |
Why?
|
Attitude | 2 | 2011 | 768 | 0.110 |
Why?
|
Cholangiopancreatography, Magnetic Resonance | 1 | 2015 | 101 | 0.110 |
Why?
|
Sample Size | 1 | 2017 | 843 | 0.110 |
Why?
|
Patient Education as Topic | 1 | 2004 | 2332 | 0.110 |
Why?
|
Sensitivity and Specificity | 9 | 2012 | 14645 | 0.110 |
Why?
|
Likelihood Functions | 2 | 2007 | 993 | 0.110 |
Why?
|
Obesity | 4 | 2024 | 13085 | 0.110 |
Why?
|
Reproducibility of Results | 6 | 2019 | 20137 | 0.110 |
Why?
|
Common Bile Duct Neoplasms | 1 | 2014 | 121 | 0.110 |
Why?
|
Ampulla of Vater | 1 | 2014 | 150 | 0.110 |
Why?
|
California | 1 | 2017 | 1435 | 0.100 |
Why?
|
Clinical Trials as Topic | 3 | 2006 | 8038 | 0.100 |
Why?
|
Program Development | 1 | 2019 | 1297 | 0.100 |
Why?
|
Pancreatic Ducts | 1 | 2015 | 331 | 0.100 |
Why?
|
Age of Onset | 4 | 2015 | 3344 | 0.100 |
Why?
|
Biomedical Research | 2 | 2019 | 3458 | 0.100 |
Why?
|
Endoscopy | 1 | 2022 | 1854 | 0.100 |
Why?
|
High-Throughput Nucleotide Sequencing | 4 | 2021 | 3665 | 0.100 |
Why?
|
Ovarian Neoplasms | 3 | 2021 | 4904 | 0.100 |
Why?
|
Patient Participation | 1 | 2021 | 1447 | 0.100 |
Why?
|
Incidence | 7 | 2023 | 21513 | 0.100 |
Why?
|
Chemoprevention | 2 | 2005 | 327 | 0.100 |
Why?
|
ras Proteins | 2 | 2014 | 1054 | 0.100 |
Why?
|
Registries | 4 | 2015 | 8347 | 0.090 |
Why?
|
Health Status Disparities | 2 | 2021 | 1878 | 0.090 |
Why?
|
Brain Neoplasms | 4 | 2022 | 9065 | 0.090 |
Why?
|
Socioeconomic Factors | 2 | 2019 | 7843 | 0.090 |
Why?
|
Ataxia Telangiectasia | 1 | 2011 | 107 | 0.090 |
Why?
|
Severity of Illness Index | 4 | 2016 | 15882 | 0.090 |
Why?
|
Follow-Up Studies | 8 | 2021 | 39243 | 0.090 |
Why?
|
Attitude to Health | 1 | 2019 | 2020 | 0.090 |
Why?
|
Referral and Consultation | 2 | 2019 | 3617 | 0.090 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 1 | 2012 | 195 | 0.090 |
Why?
|
Demography | 2 | 2007 | 1641 | 0.090 |
Why?
|
Dysplastic Nevus Syndrome | 1 | 2010 | 59 | 0.090 |
Why?
|
Rectum | 2 | 2010 | 896 | 0.090 |
Why?
|
RNA Splice Sites | 1 | 2011 | 212 | 0.090 |
Why?
|
Galactose Oxidase | 1 | 2010 | 12 | 0.090 |
Why?
|
Regression Analysis | 2 | 2017 | 6324 | 0.090 |
Why?
|
Markov Chains | 3 | 2007 | 971 | 0.090 |
Why?
|
Galactans | 1 | 2010 | 31 | 0.090 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2024 | 10380 | 0.080 |
Why?
|
Genetic Association Studies | 1 | 2019 | 2744 | 0.080 |
Why?
|
Protein Array Analysis | 1 | 2011 | 398 | 0.080 |
Why?
|
Antigens, Viral, Tumor | 1 | 2010 | 151 | 0.080 |
Why?
|
Genotype | 3 | 2016 | 13028 | 0.080 |
Why?
|
Retrospective Studies | 10 | 2024 | 81565 | 0.080 |
Why?
|
Diagnosis, Differential | 6 | 2014 | 12976 | 0.080 |
Why?
|
Disaccharides | 1 | 2010 | 170 | 0.080 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2011 | 258 | 0.080 |
Why?
|
Length of Stay | 1 | 2003 | 6490 | 0.080 |
Why?
|
DNA Methylation | 5 | 2017 | 4425 | 0.080 |
Why?
|
Computer-Assisted Instruction | 1 | 2012 | 368 | 0.080 |
Why?
|
Neoplasm Staging | 5 | 2024 | 11200 | 0.080 |
Why?
|
Odds Ratio | 4 | 2024 | 9657 | 0.080 |
Why?
|
Hypovolemia | 1 | 2008 | 48 | 0.080 |
Why?
|
Health Services Accessibility | 2 | 2024 | 5510 | 0.080 |
Why?
|
Lod Score | 2 | 2007 | 600 | 0.070 |
Why?
|
Syndrome | 2 | 2005 | 3270 | 0.070 |
Why?
|
Zea mays | 1 | 2008 | 110 | 0.070 |
Why?
|
Prospective Studies | 10 | 2021 | 54812 | 0.070 |
Why?
|
Skin Neoplasms | 2 | 2023 | 5836 | 0.070 |
Why?
|
Gene Dosage | 1 | 2012 | 1213 | 0.070 |
Why?
|
Gastric Fistula | 1 | 2008 | 73 | 0.070 |
Why?
|
DNA | 3 | 2014 | 7193 | 0.070 |
Why?
|
Quality-Adjusted Life Years | 3 | 2010 | 1740 | 0.070 |
Why?
|
Intestinal Mucosa | 4 | 2020 | 3048 | 0.070 |
Why?
|
Pancreatitis, Chronic | 1 | 2010 | 282 | 0.070 |
Why?
|
Fundoplication | 1 | 2008 | 146 | 0.070 |
Why?
|
Weight Loss | 1 | 1999 | 2711 | 0.070 |
Why?
|
Patient Care Team | 1 | 2018 | 2517 | 0.070 |
Why?
|
Moral Obligations | 1 | 2008 | 91 | 0.070 |
Why?
|
Pericarditis | 1 | 2008 | 135 | 0.070 |
Why?
|
Diverticulitis, Colonic | 1 | 2008 | 140 | 0.070 |
Why?
|
Societies, Medical | 4 | 2020 | 3955 | 0.070 |
Why?
|
Public Housing | 1 | 2008 | 140 | 0.070 |
Why?
|
Polymerase Chain Reaction | 4 | 2012 | 6059 | 0.070 |
Why?
|
Disease Progression | 2 | 2021 | 13616 | 0.070 |
Why?
|
Genetic Services | 1 | 2006 | 13 | 0.070 |
Why?
|
Alcohol Drinking | 1 | 2019 | 4044 | 0.070 |
Why?
|
Tomography, Spiral Computed | 1 | 2008 | 273 | 0.070 |
Why?
|
Pilot Projects | 3 | 2009 | 8724 | 0.070 |
Why?
|
Nuts | 1 | 2008 | 265 | 0.070 |
Why?
|
Coloring Agents | 1 | 2008 | 563 | 0.060 |
Why?
|
Chi-Square Distribution | 2 | 2012 | 3432 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2004 | 5889 | 0.060 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2007 | 378 | 0.060 |
Why?
|
Whole Body Imaging | 1 | 2008 | 281 | 0.060 |
Why?
|
Diverticulitis | 1 | 2008 | 187 | 0.060 |
Why?
|
Proportional Hazards Models | 4 | 2011 | 12529 | 0.060 |
Why?
|
Alleles | 4 | 2016 | 6892 | 0.060 |
Why?
|
Survivors | 1 | 2016 | 2375 | 0.060 |
Why?
|
Population Groups | 1 | 2006 | 209 | 0.060 |
Why?
|
Prostatic Neoplasms | 2 | 2021 | 11094 | 0.060 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2014 | 1897 | 0.060 |
Why?
|
Area Under Curve | 3 | 2015 | 1638 | 0.060 |
Why?
|
Blood Coagulation Disorders | 1 | 2008 | 351 | 0.060 |
Why?
|
Early Diagnosis | 2 | 2012 | 1186 | 0.060 |
Why?
|
Communication Barriers | 1 | 2008 | 418 | 0.060 |
Why?
|
Life Expectancy | 2 | 2004 | 1248 | 0.060 |
Why?
|
Interviews as Topic | 2 | 2015 | 2741 | 0.060 |
Why?
|
Chromosomal Instability | 1 | 2005 | 176 | 0.060 |
Why?
|
Disease Management | 1 | 2015 | 2531 | 0.060 |
Why?
|
Depression | 1 | 2024 | 8230 | 0.060 |
Why?
|
Family Practice | 1 | 2007 | 508 | 0.060 |
Why?
|
Secretin | 2 | 2015 | 57 | 0.050 |
Why?
|
Life Tables | 1 | 2004 | 366 | 0.050 |
Why?
|
Morbidity | 1 | 2009 | 1753 | 0.050 |
Why?
|
Time Factors | 6 | 2021 | 40108 | 0.050 |
Why?
|
Colostomy | 1 | 2004 | 107 | 0.050 |
Why?
|
Algorithms | 5 | 2014 | 14066 | 0.050 |
Why?
|
Hospitals | 1 | 2016 | 3887 | 0.050 |
Why?
|
Tumor Burden | 2 | 2021 | 1889 | 0.050 |
Why?
|
Neoplasm Invasiveness | 2 | 2020 | 3602 | 0.050 |
Why?
|
Frameshift Mutation | 1 | 2004 | 392 | 0.050 |
Why?
|
Confidence Intervals | 1 | 2008 | 2915 | 0.050 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2015 | 3360 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 5 | 2024 | 36548 | 0.050 |
Why?
|
Australia | 2 | 2015 | 1260 | 0.050 |
Why?
|
Research Personnel | 1 | 2006 | 589 | 0.050 |
Why?
|
Base Sequence | 3 | 2011 | 12405 | 0.050 |
Why?
|
Gene Deletion | 2 | 2010 | 2667 | 0.050 |
Why?
|
Reminder Systems | 1 | 2024 | 388 | 0.050 |
Why?
|
Probability | 1 | 2006 | 2475 | 0.050 |
Why?
|
Outpatients | 1 | 2009 | 1596 | 0.050 |
Why?
|
Gastroesophageal Reflux | 1 | 2008 | 834 | 0.040 |
Why?
|
Clinical Competence | 1 | 2016 | 4859 | 0.040 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2005 | 2271 | 0.040 |
Why?
|
Chronic Disease | 1 | 2016 | 9354 | 0.040 |
Why?
|
Vitamins | 1 | 2009 | 1631 | 0.040 |
Why?
|
Radionuclide Imaging | 1 | 2005 | 1985 | 0.040 |
Why?
|
Educational Status | 1 | 2008 | 2510 | 0.040 |
Why?
|
Income | 1 | 2009 | 1874 | 0.040 |
Why?
|
Cell Cycle Proteins | 1 | 2011 | 3436 | 0.040 |
Why?
|
Amino Acid Sequence | 2 | 2019 | 13400 | 0.040 |
Why?
|
Documentation | 1 | 2007 | 911 | 0.040 |
Why?
|
Genetic Variation | 2 | 2016 | 6612 | 0.040 |
Why?
|
Barrett Esophagus | 1 | 2004 | 494 | 0.040 |
Why?
|
Loss of Heterozygosity | 1 | 2002 | 663 | 0.040 |
Why?
|
Molecular Sequence Data | 3 | 2011 | 17597 | 0.040 |
Why?
|
Education, Medical, Graduate | 1 | 2012 | 2419 | 0.040 |
Why?
|
Ischemia | 1 | 2008 | 1904 | 0.040 |
Why?
|
Angiography | 1 | 2005 | 1589 | 0.040 |
Why?
|
Intention to Treat Analysis | 1 | 2020 | 418 | 0.040 |
Why?
|
Sequence Homology | 1 | 2019 | 197 | 0.040 |
Why?
|
Gastric Mucosa | 2 | 2020 | 602 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2024 | 1729 | 0.040 |
Why?
|
Gene Expression Profiling | 1 | 2015 | 9527 | 0.040 |
Why?
|
Survival Analysis | 2 | 2019 | 10087 | 0.040 |
Why?
|
Child | 5 | 2023 | 80573 | 0.040 |
Why?
|
Internet | 2 | 2012 | 3107 | 0.040 |
Why?
|
Case-Control Studies | 5 | 2016 | 22228 | 0.040 |
Why?
|
Anticarcinogenic Agents | 1 | 2000 | 250 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2012 | 3530 | 0.040 |
Why?
|
Health Behavior | 1 | 2009 | 2649 | 0.040 |
Why?
|
Data Collection | 1 | 2007 | 3318 | 0.040 |
Why?
|
Spain | 2 | 2010 | 483 | 0.040 |
Why?
|
Decision Making | 2 | 2011 | 3955 | 0.040 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2004 | 949 | 0.040 |
Why?
|
Motivation | 2 | 2004 | 2019 | 0.030 |
Why?
|
Neoplasms, Second Primary | 1 | 2005 | 1056 | 0.030 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 1997 | 275 | 0.030 |
Why?
|
Counseling | 1 | 2004 | 1553 | 0.030 |
Why?
|
Professional-Patient Relations | 1 | 2021 | 723 | 0.030 |
Why?
|
Epigenesis, Genetic | 1 | 2010 | 3818 | 0.030 |
Why?
|
Ileum | 1 | 1998 | 558 | 0.030 |
Why?
|
Health Literacy | 1 | 2021 | 465 | 0.030 |
Why?
|
Specimen Handling | 1 | 2020 | 704 | 0.030 |
Why?
|
Evidence-Based Medicine | 2 | 2020 | 3690 | 0.030 |
Why?
|
Sulfasalazine | 1 | 2016 | 85 | 0.030 |
Why?
|
Health Care Surveys | 2 | 2016 | 2426 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2014 | 9378 | 0.030 |
Why?
|
DNA Modification Methylases | 1 | 2016 | 207 | 0.030 |
Why?
|
Drug Therapy | 1 | 2018 | 504 | 0.030 |
Why?
|
MicroRNAs | 1 | 2011 | 3787 | 0.030 |
Why?
|
Fungal Proteins | 1 | 1999 | 901 | 0.030 |
Why?
|
Sigmoidoscopy | 1 | 2016 | 150 | 0.030 |
Why?
|
Transition Temperature | 1 | 2014 | 33 | 0.030 |
Why?
|
Anastomosis, Surgical | 1 | 1998 | 992 | 0.030 |
Why?
|
Acute Disease | 1 | 2005 | 7237 | 0.030 |
Why?
|
New Zealand | 1 | 2015 | 360 | 0.030 |
Why?
|
Treatment Outcome | 4 | 2020 | 65219 | 0.030 |
Why?
|
Hospitals, Community | 1 | 2016 | 363 | 0.030 |
Why?
|
Quality of Life | 1 | 2016 | 13468 | 0.030 |
Why?
|
Digestive System | 1 | 1995 | 244 | 0.030 |
Why?
|
Esophageal Neoplasms | 1 | 2004 | 1659 | 0.030 |
Why?
|
Polymorphism, Genetic | 1 | 2004 | 4249 | 0.030 |
Why?
|
Carcinoma in Situ | 1 | 2019 | 777 | 0.030 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2018 | 605 | 0.030 |
Why?
|
Health Planning | 1 | 2015 | 233 | 0.030 |
Why?
|
Comorbidity | 1 | 2008 | 10579 | 0.030 |
Why?
|
Duodenal Neoplasms | 1 | 2014 | 114 | 0.030 |
Why?
|
Puerto Rico | 1 | 2014 | 380 | 0.030 |
Why?
|
Terminology as Topic | 1 | 2020 | 1536 | 0.030 |
Why?
|
Genes, Tumor Suppressor | 1 | 1997 | 1060 | 0.030 |
Why?
|
Promoter Regions, Genetic | 3 | 2011 | 5784 | 0.030 |
Why?
|
Life Style | 1 | 2004 | 3928 | 0.030 |
Why?
|
Sex Distribution | 1 | 1998 | 2270 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 2009 | 14747 | 0.020 |
Why?
|
Age Distribution | 1 | 1998 | 2865 | 0.020 |
Why?
|
Health Surveys | 2 | 2015 | 4058 | 0.020 |
Why?
|
North America | 1 | 2015 | 1287 | 0.020 |
Why?
|
Prostate-Specific Antigen | 1 | 2021 | 2463 | 0.020 |
Why?
|
Chromogranins | 1 | 2012 | 159 | 0.020 |
Why?
|
Cost-Benefit Analysis | 2 | 2010 | 5531 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2008 | 6545 | 0.020 |
Why?
|
Infant | 1 | 2013 | 36427 | 0.020 |
Why?
|
Boston | 1 | 2004 | 9335 | 0.020 |
Why?
|
Cecum | 1 | 2012 | 231 | 0.020 |
Why?
|
Validation Studies as Topic | 1 | 2011 | 162 | 0.020 |
Why?
|
beta Catenin | 1 | 2016 | 1047 | 0.020 |
Why?
|
Cancer Vaccines | 1 | 2018 | 1042 | 0.020 |
Why?
|
Intubation, Gastrointestinal | 1 | 2012 | 166 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2021 | 4887 | 0.020 |
Why?
|
Mutant Proteins | 1 | 2012 | 487 | 0.020 |
Why?
|
Video Recording | 1 | 2016 | 977 | 0.020 |
Why?
|
Point Mutation | 1 | 2015 | 1591 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2020 | 6309 | 0.020 |
Why?
|
Research Design | 1 | 2006 | 6206 | 0.020 |
Why?
|
Diet | 1 | 2008 | 8087 | 0.020 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 1999 | 1836 | 0.020 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2005 | 2431 | 0.020 |
Why?
|
Rosaniline Dyes | 1 | 2010 | 51 | 0.020 |
Why?
|
Michigan | 1 | 2010 | 329 | 0.020 |
Why?
|
Core Binding Factor Alpha 3 Subunit | 1 | 2010 | 58 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2020 | 6506 | 0.020 |
Why?
|
Haplotypes | 2 | 2011 | 2726 | 0.020 |
Why?
|
Canada | 1 | 2015 | 2120 | 0.020 |
Why?
|
Italy | 1 | 2011 | 851 | 0.020 |
Why?
|
Women | 1 | 2011 | 225 | 0.020 |
Why?
|
Pregnancy | 2 | 2011 | 30233 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 3 | 2021 | 20700 | 0.020 |
Why?
|
Duodenum | 1 | 2012 | 496 | 0.020 |
Why?
|
Germany | 1 | 2011 | 882 | 0.020 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2010 | 178 | 0.020 |
Why?
|
Introns | 1 | 2011 | 965 | 0.020 |
Why?
|
Europe | 1 | 2015 | 3430 | 0.020 |
Why?
|
Weight Gain | 1 | 1999 | 2356 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2024 | 3407 | 0.020 |
Why?
|
Asymptomatic Diseases | 1 | 2012 | 586 | 0.020 |
Why?
|
Hospitalization | 1 | 2008 | 10811 | 0.020 |
Why?
|
Women's Health | 1 | 1998 | 2081 | 0.020 |
Why?
|
Long Interspersed Nucleotide Elements | 1 | 2010 | 332 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2018 | 6840 | 0.020 |
Why?
|
Zebrafish | 1 | 2019 | 3035 | 0.020 |
Why?
|
Smoking | 1 | 2024 | 9082 | 0.020 |
Why?
|
False Negative Reactions | 1 | 2008 | 570 | 0.020 |
Why?
|
Binding Sites | 1 | 2016 | 6001 | 0.020 |
Why?
|
Waist-Hip Ratio | 1 | 2008 | 521 | 0.020 |
Why?
|
Hysterectomy | 1 | 2012 | 864 | 0.020 |
Why?
|
Body Mass Index | 2 | 2008 | 13046 | 0.020 |
Why?
|
Feeding Behavior | 1 | 1999 | 3209 | 0.020 |
Why?
|
Netherlands | 1 | 2011 | 2277 | 0.020 |
Why?
|
Colitis, Ulcerative | 1 | 1998 | 1912 | 0.020 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2015 | 1188 | 0.020 |
Why?
|
Genomic Instability | 1 | 2010 | 716 | 0.020 |
Why?
|
Exons | 1 | 2011 | 2393 | 0.020 |
Why?
|
Quality Assurance, Health Care | 1 | 2015 | 2171 | 0.020 |
Why?
|
Waist Circumference | 1 | 2008 | 934 | 0.010 |
Why?
|
Genome-Wide Association Study | 2 | 2016 | 12803 | 0.010 |
Why?
|
Acrylamide | 1 | 2004 | 59 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2014 | 2879 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2016 | 16040 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2016 | 3477 | 0.010 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2010 | 1138 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2019 | 10433 | 0.010 |
Why?
|
Survival Rate | 1 | 1998 | 12827 | 0.010 |
Why?
|
Fellowships and Scholarships | 1 | 2012 | 1134 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2014 | 3561 | 0.010 |
Why?
|
Genome, Human | 1 | 2015 | 4443 | 0.010 |
Why?
|
Magnetics | 1 | 2004 | 586 | 0.010 |
Why?
|
Genetic Linkage | 1 | 2007 | 2342 | 0.010 |
Why?
|
Monte Carlo Method | 1 | 2007 | 1238 | 0.010 |
Why?
|
Computer Simulation | 1 | 2015 | 6254 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2018 | 17071 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2012 | 2782 | 0.010 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2010 | 2054 | 0.010 |
Why?
|
Genomics | 1 | 2015 | 5926 | 0.010 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2008 | 2029 | 0.010 |
Why?
|
Cooperative Behavior | 1 | 2006 | 1512 | 0.010 |
Why?
|
Recurrence | 1 | 2011 | 8494 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 2008 | 2702 | 0.010 |
Why?
|
Child, Preschool | 1 | 2020 | 42511 | 0.010 |
Why?
|
CpG Islands | 1 | 2002 | 1207 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2010 | 4399 | 0.010 |
Why?
|
Endoscopes | 1 | 1998 | 169 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2008 | 5300 | 0.010 |
Why?
|
Genome | 1 | 2004 | 1753 | 0.010 |
Why?
|
Health Status | 1 | 2009 | 4086 | 0.010 |
Why?
|
Mammography | 1 | 2003 | 2424 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2014 | 15808 | 0.010 |
Why?
|
Animals | 1 | 2019 | 168800 | 0.000 |
Why?
|
Gastrointestinal Diseases | 1 | 1995 | 1204 | 0.000 |
Why?
|
Arthritis, Rheumatoid | 1 | 1995 | 3743 | 0.000 |
Why?
|